Hyper IgE Syndrome Latest Advances

Recurrent severe infections in a child with STAT3-associated hyper-IgE syndrome.

Journal: JAAD case reports

Published: December 11, 2025

Environmental exposures, epithelial barrier dysfunction, and the evolving landscape of allergic disorders and asthma.

Journal: Current opinion in allergy and clinical immunology

Published: December 08, 2025

DOCK8 deficiency.

Journal: Current opinion in allergy and clinical immunology

Published: October 29, 2025

Case report. Job syndrome as an unusual finding in a pediatric patient

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: October 02, 2025

Successful Use of Tralokinumab in a Pediatric Patient With STAT3 Hyper-IgE Syndrome Following Dupilumab-Associated Conjunctivitis.

Journal: International journal of dermatology

Published: September 09, 2025

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 04, 2025

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 04, 2025

Understanding and Managing Hyper IgE Syndromes.

Journal: ImmunoTargets and therapy

Published: September 01, 2025

STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome.

Journal: Science advances

Published: August 29, 2025

Pediatric Severe Eosinophilia: Etiological Spectrum, Diagnostic Algorithm, and Case-Based Insights From a Tertiary Care Center.

Journal: International journal of laboratory hematology

Published: August 28, 2025

Audiovestibular Dysfunction in Hyper-IgE Syndrome: A Systematic Review of Characteristics, Pathophysiology, Diagnosis, and Management.

Journal: International journal of molecular sciences

Published: August 21, 2025

Upadacitinib for Treatment of Hyper-IgE Syndrome.

Journal: JAMA dermatology

Published: August 06, 2025

Filters

Recurrent severe infections in a child with STAT3-associated hyper-IgE syndrome.

Recurrent severe infections in a child with STAT3-associated hyper-IgE syndrome.

Environmental exposures, epithelial barrier dysfunction, and the evolving landscape of allergic disorders and asthma.

Environmental exposures, epithelial barrier dysfunction, and the evolving landscape of allergic disorders and asthma.

DOCK8 deficiency.

DOCK8 deficiency.

Case report. Job syndrome as an unusual finding in a pediatric patient

Case report. Job syndrome as an unusual finding in a pediatric patient

Successful Use of Tralokinumab in a Pediatric Patient With STAT3 Hyper-IgE Syndrome Following Dupilumab-Associated Conjunctivitis.

Successful Use of Tralokinumab in a Pediatric Patient With STAT3 Hyper-IgE Syndrome Following Dupilumab-Associated Conjunctivitis.

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Obesity and hepatic steatosis in STAT3 hyper-IgE syndrome.

Understanding and Managing Hyper IgE Syndromes.

Understanding and Managing Hyper IgE Syndromes.

STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome.

STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome.

Pediatric Severe Eosinophilia: Etiological Spectrum, Diagnostic Algorithm, and Case-Based Insights From a Tertiary Care Center.

Pediatric Severe Eosinophilia: Etiological Spectrum, Diagnostic Algorithm, and Case-Based Insights From a Tertiary Care Center.

Audiovestibular Dysfunction in Hyper-IgE Syndrome: A Systematic Review of Characteristics, Pathophysiology, Diagnosis, and Management.

Audiovestibular Dysfunction in Hyper-IgE Syndrome: A Systematic Review of Characteristics, Pathophysiology, Diagnosis, and Management.

Upadacitinib for Treatment of Hyper-IgE Syndrome.

Upadacitinib for Treatment of Hyper-IgE Syndrome.